Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02919098 · ClinicalTrials.gov registry record · NA

In-School Evaluation of Bystander: A Game-Based Intervention for Sexual Violence Prevention

A NA study, sponsored by University of Chicago.

Completed
Registry status
NA
Development phase
601
Enrollment target

NCT02919098: Completed NA study, sponsored by University of Chicago.

NCT02919098 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 601 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02919098, a NA study, has completed, sponsored by University of Chicago.

COMPLETED
Registry status
NA
Development phase
601 participants
Enrollment target

Study Summary

The investigators have developed a game-based sexual violence prevention program that uses a bystander intervention approach. This program is called Bystander and was designed for use with high school students in grades 9-12. The goal of this research is to evaluate the efficacy and feasibility of Bystander when implemented in a school setting. The research will capture data on knowledge about sexual violence and harassment, as well as attitudes, self-efficacy, perceived social norms and behavioral intentions around bystander behaviors. This research will consist of a baseline survey, program participation, a immediate post-program survey, and a 3-month follow up survey with youth participants. It will also involve qualitative in-depth interviews with school staff and administration about the program.

Primary Outcome

measured via validated 11-item Bystander Attitude Scale-Revised by McMahon et al 2014

Interventions

  • BEHAVIORAL Bystander, a game-based bystander intervention program
  • BEHAVIORAL Infection City, a game-based program about meningitis

Trial Details

FieldValue
Enrollment Target 601 participants
Start Date 2016-10
Est. Completion 2017-10
Phase NA
University of Chicago

796 total trials

What the finished NCT02919098 record still lists

NCT02919098 is an interventional study that assigns participants to a tested intervention. The registered 601 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower).

The record links to 0 conditions, and to 2 interventions - of which Bystander, a game-based bystander intervention program is the first listed.

NCT02919098 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02919098 about?

NCT02919098 is a clinical study titled "In-School Evaluation of Bystander: A Game-Based Intervention for Sexual Violence Prevention". The investigators have developed a game-based sexual violence prevention program that uses a bystander intervention approach. This program is called Bystander and was designed for use with high school students in grades 9-12. The goal of this research is to evaluate the efficacy and feasibility of B...

What is the current status of trial NCT02919098?

This trial is currently completed. It is a NA study. The enrollment target is 601 participants. The study started on 2016-10. Estimated completion is 2017-10.

What interventions are being tested in trial NCT02919098?

The interventions under investigation include: Bystander, a game-based bystander intervention program (BEHAVIORAL), Infection City, a game-based program about meningitis (BEHAVIORAL).

Who is sponsoring clinical trial NCT02919098?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02919098's enrollment target sits among peer trials

601 162nd of 2000 higher than 1,839 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00004317 · 600 participants · Phase 4

    Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis

  • NCT00209235 · 600 participants · NA

    Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments

  • NCT01473784 · 600 participants · NA

    Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck

  • NCT01866371 · 600 participants

    High Resolution Retinal Imaging

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02919098, the US trial registry maintained by the National Library of Medicine. NCT02919098 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.